MedPage Today

FDA Tweaks JAK Inhibitor Indication in Inflammatory Bowel Disease

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for ...

How to tell if you have IBD and the difference between Crohn's disease and ulcerative colitis

Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

Crohn’s disease is a lifelong condition, but proper treatment makes all the difference

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...

Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease

“This continued NIH funding validates Trethera’s innovative approach of targeting dCK, a key metabolic vulnerability in ...
Stocktwits on MSN

AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug

AbbVie (ABBV) on Monday said that the U.S. Food and Drug Administration has approved an update to the indication statement for its drug Rinvoq for the treatment of adults with moderately to severely ...

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ® (upadacitinib) ...